Home  >  Products  >  MAFG (v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)) Blocking Peptide (the middle region of protein) (100ug)
MAFG (v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)) Blocking Peptide (the middle region of protein) (100ug)

MAFG (v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAFG antibody (Catalogue #: ARP32691_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP32691
Size: 100 ug
Weight: 18kDa
Gene: 4097
Format: Lyophilized powder
Target: Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves. However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins and recruiting them to specific DNA-binding sites. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Transcription factor, component of erythroid-specific transcription factor NF-E2.
Alternative names: MGC13090; MGC20149
See Full Product Listings >